151 related articles for article (PubMed ID: 16076370)
1. Treatment with cytapheresis for antineutrophil cytoplasmic antibody-associated renal vasculitis and its effect on anti-inflammatory factors.
Hasegawa M; Watanabe A; Takahashi H; Takahashi K; Kasugai M; Kawamura N; Kushimoto H; Murakami K; Tomita M; Nabeshima K; Oohashi A; Kondou F; Ooshima H; Hiki Y; Sugiyama S
Ther Apher Dial; 2005 Aug; 9(4):297-302. PubMed ID: 16076370
[TBL] [Abstract][Full Text] [Related]
2. Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-associated vasculitis: a pilot study of 21 patients.
Hasegawa M; Ohashi A; Kabutan N; Hiramatsu S; Kato M; Murakami K; Tomita M; Nabeshima K; Hiki Y; Sugiyama S
Ther Apher Dial; 2006 Oct; 10(5):412-8. PubMed ID: 17096695
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of granulocytapheresis and leukocytapheresis for the treatment of microscopic polyangiitis.
Hasegawa M; Kawamura N; Murase M; Koide S; Kushimoto H; Murakami K; Tomita M; Hiki Y; Shikano M; Sugiyama S
Ther Apher Dial; 2004 Jun; 8(3):212-6. PubMed ID: 15154873
[TBL] [Abstract][Full Text] [Related]
4. Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis: report of five cases.
Hasegawa M; Kawamura N; Kasugai M; Koide S; Murase M; Asano S; Toba T; Kushimoto H; Murakami K; Tomita M; Shikano M; Sugiyama S
Ther Apher; 2002 Dec; 6(6):443-9. PubMed ID: 12460408
[TBL] [Abstract][Full Text] [Related]
5. Effects of cytapheresis on tumor necrosis factor receptor and on expression of CD63 in myeloperoxidase--antineutrophil cytoplasmic autoantibody-associated vasculitis.
Hasegawa M; Nishii C; Kabutan N; Kato M; Ohashi A; Nakai S; Murakami K; Tomita M; Nabeshima K; Hiki Y; Oshima H; Sugiyama S
Ther Apher Dial; 2007 Oct; 11(5):337-40. PubMed ID: 17845393
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
[TBL] [Abstract][Full Text] [Related]
7. Apheresis for MPO-ANCA-associated RPGN-indications and efficacy: lessons learned from Japan nationwide survey of RPGN.
Yamagata K; Hirayama K; Mase K; Yamaguchi N; Kobayashi M; Takahashi H; Koyama A
J Clin Apher; 2005 Dec; 20(4):244-51. PubMed ID: 15880406
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibody-associated vasculitis complicated with diffuse alveolar hemorrhage: a study of 12 cases.
Lin Y; Zheng W; Tian X; Zhang X; Zhang F; Dong Y
J Clin Rheumatol; 2009 Oct; 15(7):341-4. PubMed ID: 20009969
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
Okano K; Yumura W; Nitta K; Honda K; Uchida K; Nihei H
Clin Nephrol; 2001 Apr; 55(4):275-81. PubMed ID: 11334312
[TBL] [Abstract][Full Text] [Related]
10. [A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report].
Mizutani A; Tanaka I; Katayama M; Oshima H; Komatsu Y; Asano S; Kato K; Matsumura H; Ishii K; Miyama H; Nagai T; Kato K; Fukaya S; Yoshida S; Hasegawa M; Kawashima S; Torikai K
Ryumachi; 2000 Oct; 40(5):828-32. PubMed ID: 11215162
[TBL] [Abstract][Full Text] [Related]
11. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.
Chen YX; Yu HJ; Ni LY; Zhang W; Xu YW; Ren H; Chen XN; Wang XL; Li X; Pan XX; Wang WM; Chen N
J Rheumatol; 2007 Dec; 34(12):2451-6. PubMed ID: 17985400
[TBL] [Abstract][Full Text] [Related]
12. Improvements in treatment strategies for patients with antineutrophil cytoplasmic antibody-associated rapidly progressive glomerulonephritis.
Hotta O; Ishida A; Kimura T; Taguma Y
Ther Apher Dial; 2006 Oct; 10(5):390-5. PubMed ID: 17096692
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis.
Jayne DR; Gaskin G; Rasmussen N; Abramowicz D; Ferrario F; Guillevin L; Mirapeix E; Savage CO; Sinico RA; Stegeman CA; Westman KW; van der Woude FJ; de Lind van Wijngaarden RA; Pusey CD;
J Am Soc Nephrol; 2007 Jul; 18(7):2180-8. PubMed ID: 17582159
[TBL] [Abstract][Full Text] [Related]
14. Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis.
Neumann I; Kain R; Regele H; Soleiman A; Kandutsch S; Meisl FT
Nephrol Dial Transplant; 2005 Jan; 20(1):96-104. PubMed ID: 15546891
[TBL] [Abstract][Full Text] [Related]
15. Crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil-cytoplasmic antibodies: first report on the efficacy of primary anti-TNF-alpha treatment.
Zaenker M; Arbach O; Helmchen U; Glorius P; Ludewig S; Braasch E
Int J Tissue React; 2004; 26(3-4):85-92. PubMed ID: 15648440
[TBL] [Abstract][Full Text] [Related]
16. Two cases of ANCA-associated vasculitis in post-transplant kidney: relapse and de novo.
Tabata H; Honda K; Moriyama T; Itabashi M; Taneda S; Takei T; Tanabe K; Teraoka S; Yamaguchi Y; Oda H; Nitta K
Clin Transplant; 2009 Aug; 23 Suppl 20():49-53. PubMed ID: 19594597
[TBL] [Abstract][Full Text] [Related]
17. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study.
Haubitz M; Schellong S; Göbel U; Schurek HJ; Schaumann D; Koch KM; Brunkhorst R
Arthritis Rheum; 1998 Oct; 41(10):1835-44. PubMed ID: 9778225
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis.
Ito-Ihara T; Ono T; Nogaki F; Suyama K; Tanaka M; Yonemoto S; Fukatsu A; Kita T; Suzuki K; Muso E
Nephron Clin Pract; 2006; 102(1):c35-42. PubMed ID: 16174989
[TBL] [Abstract][Full Text] [Related]
20. Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases.
Feldmann M; Pusey CD
J Am Soc Nephrol; 2006 May; 17(5):1243-52. PubMed ID: 16624928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
